AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -60.0% | 59,050 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $10,000 | -64.3% | 59,050 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $28,000 | -9.7% | 59,050 | +9.3% | 0.00% | 0.0% |
| Q4 2021 | $31,000 | -65.6% | 54,050 | 0.0% | 0.00% | -71.4% |
| Q3 2021 | $90,000 | 0.0% | 54,050 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $90,000 | +21.6% | 54,050 | +22.7% | 0.01% | +20.0% |
| Q1 2021 | $74,000 | +13.8% | 44,050 | +7.3% | 0.01% | 0.0% |
| Q4 2020 | $65,000 | +91.2% | 41,050 | +13.9% | 0.01% | +66.7% |
| Q3 2020 | $34,000 | +385.7% | 36,050 | +115.2% | 0.00% | +200.0% |
| Q1 2020 | $7,000 | -12.5% | 16,750 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | +33.3% | 16,750 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | – | 16,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |